<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Immunotherapy | Seppälä Lab</title><link>https://www.seppalalab.org/tag/immunotherapy/</link><atom:link href="https://www.seppalalab.org/tag/immunotherapy/index.xml" rel="self" type="application/rss+xml"/><description>Immunotherapy</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en</language><lastBuildDate>Tue, 06 May 2025 00:00:00 +0000</lastBuildDate><image><url>https://www.seppalalab.org/media/logo_hu_e3f0d28ad302f75b.png</url><title>Immunotherapy</title><link>https://www.seppalalab.org/tag/immunotherapy/</link></image><item><title>Advancing Cancer Research Through Foundation and Donor Funding</title><link>https://www.seppalalab.org/post/2025-cancer-foundation-funding/</link><pubDate>Tue, 06 May 2025 00:00:00 +0000</pubDate><guid>https://www.seppalalab.org/post/2025-cancer-foundation-funding/</guid><description>&lt;p&gt;Cancer Foundation Finland (Syöpäsäätiö) has awarded Toni Seppälä a EUR 150,000 grant to support a two-year patient study aimed at optimizing colorectal cancer treatment using modern methods.&lt;/p&gt;
&lt;p&gt;The study will use tumor DNA analysis from blood samples to identify effective and safe treatment combinations for individual patients, with a focus on colorectal cancer subtypes that respond to immunotherapy.&lt;/p&gt;
&lt;p&gt;&lt;a href="https://syopasaatio.fi/huippututkija-tutkimus-tuo-toivoa/" target="_blank" rel="noopener"&gt;Read the full article at Syöpäsäätiö →&lt;/a&gt;&lt;/p&gt;</description></item></channel></rss>